GlassScriptPhysician profile
David Scott Andrew
NPI 1780655977
$2,113.01
in general payments reported to CMS, 2019-2025
16 companies · $51.33 in 2025
The $51.33 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $532 · 2020: $186 · 2021: $259 · 2022: $201 · 2023: $713 · 2024: $171 · 2025: $51.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $934.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $446.22 | 2021-2023 | Puraply |
| Boston Scientific Corporation | $385.96 | 2019-2024 | |
| Stryker Corporation | $312.19 | 2019 | |
| Horizon Therapeutics Plc | $285.19 | 2020-2022 | |
| Convatec INC. | $141.72 | 2023 | |
| Treace Medical Concepts, INC. | $125.00 | 2023 | |
| Medtronic, INC. | $85.58 | 2023-2024 | Intellis Adaptivestim |
| Paratek Pharmaceuticals, INC. | $76.84 | 2022-2025 | Nuzyra |
| Medtronic Vascular, INC. | $66.90 | 2020 | |
| Reprise Biomedical, INC. | $53.83 | 2023 | Miro3d |
| Globus Medical, INC. | $34.00 | 2025 | Senza |
| Djo, LLC | $25.82 | 2024 | Cmf |
| Kowa Pharmaceuticals America, INC. | $22.02 | 2023 | Seglentis |
| Amgen INC. | $21.08 | 2024 | Krystexxa |
| Coastal Medical Technologies LLC | $15.66 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.00 | 2023 | Dalvance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Andrew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.